Boosting CGT access: a global consideration with wide-spanning benefits
Experts say wider patient access to CGTs hinges on further infrastructure developments and the movement of therapies into the community setting.
Experts say wider patient access to CGTs hinges on further infrastructure developments and the movement of therapies into the community setting.
BMS enhances its AI computing power as big pharma race to stay competitive within the shifting global landscape.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Turning AI skeptics into AI advocates through high-integrity data
Keeping pace with generative AI in pharmaceutical and healthcare organisations
Pharma Meets AI Conference 2026: Key barriers to scaling AI in drug development
Advancing pressure protection in biopharma: how integrated bypass technology elevates single-use pump design